IP Library Granted Patent US 10,801,045
Granted Patent B2
US 10,801,045 · App. 15/867,209 · Granted Oct 13, 2020

Methods for making chemoautotrophic cells by engineering an energy conversion pathway and a carbon fixation pathway

Inventors: Curt R. Fischer (Sunnyvale, CA); Austin J. Che (Cambridge, MA); Reshma P. Shetty (Boston, MA); Jason R. Kelly (Cambridge, MA)
Assignee: Ginkgo Bioworks, Inc.
C12P7/40C12N9/0006C12N9/0051C12N15/52C12N15/70C12P5/00C12P7/00C12P7/16C12Y101/05006C12Y108/05004Y02E50/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,801,045
App. No.
15/867,209
Granted
Oct 13, 2020
Kind
B2
Abstract

The present disclosure identifies pathways, mechanisms, systems and methods to confer chemoautotrophic production of carbon-based products of interest, such as sugars, alcohols, chemicals, amino acids, polymers, fatty acids and their derivatives, hydrocarbons, isoprenoids, and intermediates thereof, in organisms such that these organisms efficiently convert inorganic carbon to organic carbon-based products of interest using inorganic energy, such as formate, and in particular the use of organisms for the commercial production of various carbon-based products of interest.

Claims (18)

1. A method of making a chemoautotrophic cell, the method comprising steps of:

(i) engineering in a cell an energy conversion pathway comprising a recombinant formate dehydrogenase or a recombinant sulfide-quinone oxidoreductase, wherein the recombinant formate dehydrogenase is encoded by any one of SEQ ID NOs:1-4 or a homolog thereof having at least 80% sequence identity thereto, or comprises any one of SEQ ID NOs:5-8 or a homolog thereof having at least 80% sequence identity thereto, and the recombinant sulfide-quinone oxidoreductase is encoded by any one of SEQ ID NOs:9-16 or a homolog thereof having at least 80% sequence identity thereto;

wherein the energy conversion pathway transfers energy from an extracellular inorganic energy source to a reducing cofactor, and

(ii) engineering in the cell a carbon fixation pathway that utilizes the reducing cofactor to convert inorganic carbon to a reduced organic carbon molecule.

2. The method of claim 1 , wherein the energy conversion pathway comprises an enzyme heterologous to the cell.

3. The method of claim 1 , wherein the energy conversion pathway consists essentially of enzymes exogenous to the cell.

4. The method of claim 1 , wherein the energy conversion pathway comprises an enzyme that is endogenous to the cell.

5. The method of claim 4 , wherein the enzyme is modified, wherein the modification comprises addition of a solubility tag, removal of a leader sequence, or addition of a targeting sequence.

6. The method of claim 1 , wherein the carbon fixation pathway comprises an enzyme exogenous to the cell.

7. The method of claim 1 , wherein the carbon fixation pathway consists essentially of enzymes exogenous to the cell.

8. The method of claim 1 , wherein the carbon fixation pathway comprises an enzyme that is endogenous to the cell.

9. The method of claim 8 , wherein the enzyme is modified, and wherein the modification comprises addition of a solubility tag, removal of a leader sequence, or addition of a targeting sequence.

10. The method of claim 1 , wherein the carbon fixation pathway is derived from a pathway comprising one or more of 3-hydroxypropionate (3-HPA) bicycle, ribulose monophosphate (RuMP) cycle, Calvin-Benson-Bassham cycle or the reductive pentose phosphate (RPP) cycle, and reductive tricarboxylic acid (rTCA) cycle.

11. The method of claim 1 , wherein the extracellular inorganic energy source comprises one or more of formate, formic acid, methane, carbon monoxide, carbonyl sulfide, carbon disulfide, hydrogen sulfide, bisulfide anion, thiosulfate, elemental sulfur, molecular hydrogen, ferrous iron, ammonia, cyanide ion, and hydrocyanic acid.

12. The method of claim 1 , wherein the reducing cofactor comprises one or more of NADH, NADPH, ubiquinol, menaquinol, cytochromes, flavins and ferredoxin.

13. The method of claim 1 , wherein the reduced organic carbon molecule comprises one or more of acetyl-coA, pyruvate, pyruvic acid, 3-hydropropionate, 3-hydroxypropionic acid, glycolate, glycolic acid, glyoxylate, glyoxylic acid, dihydroxyacetone phosphate, glyceraldehyde-3-phosphate, malate, malic acid, lactate, lactic acid, acetate, acetic acid, citrate, and citric acid.

14. The method of claim 1 , further comprising a step of engineering a carbon biosynthetic pathway that produces an organic carbon molecule derived from a reduced organic carbon molecule.

15. The method of claim 14 , wherein the derived organic carbon molecule comprises one or more of alcohols, fatty acids, fatty acid derivatives, fatty alcohols, fatty acid esters, wax esters, hydrocarbons, alkanes, polymers, fuels, commodity chemicals, specialty chemicals, carotenoids, isoprenoids, sugars, sugar phosphates, central metabolites, pharmaceuticals and pharmaceutical intermediates.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 22, 2018
From: FISCHER, CURT R.; CHE, AUSTIN J.; SHETTY, RESHMA P.; KELLY, JASON R.
To: GINKGO BIOWORKS, INC.
Reel/Frame 045316/0243 →
Continuity (3)
Continuation 14354354
Continuation In Part 13285919 · Oct 31, 2011
Related Publication 20180223317A1 · Aug 9, 2018
Cited By (1)
US 12,241,109